Twist Bioscience ( (TWST) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual movement.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Twist Bioscience shares are sliding as investors react to a major insider stock sale by a company director, combined with additional selling by Cathie Wood’s ARK Invest, which has further cut its stake. These moves are fueling worries that key insiders and a high-profile institutional holder may see limited near-term upside.
Adding to the pressure, sentiment is still weak after Twist’s recent fiscal second-quarter 2026 earnings report, where a larger-than-expected loss per share overshadowed a small revenue beat and an improved full-year outlook. Analysts and traders are now reassessing their expectations, with some likely trimming price targets or delaying bullish calls until profitability trends stabilize.
More about Twist Bioscience
YTD Price Performance: 66.93%
Average Trading Volume: 1,261,605
Technical Sentiment Signal: Strong Buy
Current Market Cap: $3.3B
For further insights into TWST stock on TipRanks’ Stock Analysis page.
See more of today’s top stock gainers and losers.